Español

TITULO (Dose Comparisons of Clopidogreland Aspirin in Acute Coronary Syndromes)
AUTORES: The CURRENT–OASIS 7 Investigators* (Members of the writing committee (ShamirR. Mehta, M.D., McMasterUniversity and Hamilton Health Sciences, Hamilton, ON, Canada; Jean-Pierre Bassand, M.D., University Hospital Jean Minjoz, Besançon, France; Susan Chrolavicius, B.A., McMaster University and Hamilton HealthSciences, Hamilton, ON, Canada; Rafael Diaz, M.D., Estudios Clinicos Latinoamérica, Rosario, Argentina; John W. Eikelboom, M.D., Mc- Master University and Hamilton Health Sciences, Hamilton, ON,Canada; Keith A.A. Fox, M.B., Ch.B., Royal Infirmary of Edinburgh, University of Edinburgh, Edinburgh; Christopher B. Granger, M.D., Duke Clinical Research Institute, Durham, NC; Sanjit Jolly, M.D.,McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada; Campbell D. Joyner, M.D., Sunnybrook Health Sciences Centre, University of Toronto, Toronto; Hans- Jurgen Rupprecht, M.D., SecondMedical Clinic, Ruesselsheim, Germany; Petr Widimsky, M.D., University Hospital Kralovske Vinohrady, Prague, Czech Republic; and Rizwan Afzal, M.Sc., Janice Pogue, M.Sc., and Salim Yusuf, M.B., B.S.,D.Phil., McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada) assume responsibility for the integrity of the article. Address reprint requests to Dr. Mehta at the David Braley Cardiac,Vascular and Stroke Institute, Hamilton Health Sciences, Rm. 3-119, 237 Barton St., E., Hamilton, ON L8L 2X2, Canada, orat smehta@mcmaster.ca.)

REFERENCIA BIBLIOGRAFICA (n engl j med 363;10nejm.org september 2, 2010)
ANALISIS Y COMENTARIOS
* EL OBJETIVO PRINCIPAL Y ESPECIFICOS DE ESTE ESTUDIOS ES O EL PROBLEMA A SOLUCIONAR ES :
(EJEMPLO)
¿Puede la administración de dexametasona mejorarel resultado clínico de la paciente con síndrome de HELLP?

* RELEVANCIA DE LA INVESTIGACION
(ANALISIS DE LA METODOLOGIA UTILIZADA Y ESTABLECER FORTALEZAS Y DEBILIDADES DEL ESTUDIO)

*...